Further processing options
Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist
Saved in:
Journal Title: | Molecular Cancer Therapeutics |
---|---|
Authors and Corporations: | , , , , , , |
In: | Molecular Cancer Therapeutics, 11, 2012, 11, p. 2541-2546 |
Type of Resource: | E-Article |
Language: | English |
published: |
American Association for Cancer Research (AACR)
|
Subjects: |